GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $490,000 | +114.9% | 7,200 | +0.9% | 0.00% | – |
| Q2 2022 | $228,000 | +3.6% | 7,134 | -0.3% | 0.00% | – |
| Q1 2022 | $220,000 | -2.2% | 7,152 | -7.0% | 0.00% | – |
| Q4 2021 | $225,000 | -13.8% | 7,688 | +3.1% | 0.00% | – |
| Q2 2021 | $261,000 | -8.1% | 7,457 | +7.0% | 0.00% | – |
| Q1 2021 | $284,000 | -5.3% | 6,967 | +0.4% | 0.00% | – |
| Q4 2020 | $300,000 | -2.3% | 6,936 | +24.7% | 0.00% | – |
| Q3 2020 | $307,000 | -15.2% | 5,561 | -3.1% | 0.00% | – |
| Q2 2020 | $362,000 | -44.0% | 5,739 | -54.6% | 0.00% | -100.0% |
| Q1 2020 | $646,000 | -8.8% | 12,644 | +42.0% | 0.00% | 0.0% |
| Q4 2019 | $708,000 | +108.2% | 8,903 | +27.0% | 0.00% | – |
| Q3 2019 | $340,000 | – | 7,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |